Dermatol. praxi. 2022;16(3):157-159 | DOI: 10.36290/der.2022.031

An unussual type of bullous disease

MUDr. Eva Valihrachová
Kožní ambulance, Uherskohradišťská nemocnice

Next case report describes 57 year old patient with personal history of lichen ruber planus, who suddenly developed bullous diseae.

Keywords: lichen ruber planus, bullous lichen planus, acitretin.

Accepted: October 11, 2022; Published: October 17, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Valihrachová E. An unussual type of bullous disease. Dermatol. praxi. 2022;16(3):157-159. doi: 10.36290/der.2022.031.
Download citation

References

  1. Herzogová J. Klinická dermatovenerologie, 2019, Mladá Fronta, 199-203.
  2. Angeliki Liakopoulou and Efstathios Rallis, Bullous lichen planus - a review, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5439688/.
  3. Changzheng Huang, Siyuand Chenm Zhixiang Liu, Juan Tao, Chusen Wang , Youwen Zhou,Familial bullous lichen planus: Pedigree analysis and clinical charakteristics, Journal of cutaneous medicine and surgery 9, Article number 217 (2005). Go to original source... Go to PubMed...
  4. Verma R, Vasudevan B, Kinra P, Vijendran P, Badad A, Singh V. Bullous lichen planus. Indian J Dermatol Venereol Leprol 2014;80:279, https://ijdvl.com/bullous-lichen-planus/. Go to original source... Go to PubMed...
  5. Patil Achana, Prasad Shiva, Ashok L, Sujatha GP. Oral bullous lichen planus, Case report and review of management, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532804/.
  6. Efstathios Rallis, Angeliki Liakopoulou, Constantinos Christodoulopoulos, Alexandros Katoulis, Successful treatment of bullous lichen planus with acitretin monotherapy. Review of treatment options for bullous lichen planus and case report, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392245/.
  7. Lebwohl MG, Heymann WR, Berth-Jones John, Coulson Ian, Treatment of skin diseases, third edition, Elsevier limited, 2010, 123.
  8. Wolff K, Johnson AR. Fitzpatrick's color atlas and synopsis of clinical dermatology, fifth edition, 2005, The MvGraw-Hill Companies, 123-126.




Dermatology for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.